Dialysis-associated peritonitis in children

被引:65
作者
Chadha, Vimal [2 ]
Schaefer, Franz S. [3 ]
Warady, Bradley A. [1 ,4 ]
机构
[1] Univ Missouri, Sch Med, Childrens Mercy Hosp, Kansas City, MO 64108 USA
[2] Virginia Commonwealth Univ, Med Ctr, Dept Pediat, Nephrol Sect, Richmond, VA USA
[3] Heidelberg Univ, Ctr Pediat & Adolescent Med, Sect Pediat Nephrol, Heidelberg, Germany
[4] Childrens Mercy Hosp, Dept Pediat, Nephrol Sect, Kansas City, MO 64108 USA
关键词
Antibiotics; Children; Infection; Peritonitis; Peritoneal dialysis; RESISTANT STAPHYLOCOCCUS-AUREUS; CULTURE-NEGATIVE PERITONITIS; EXIT-SITE INFECTIONS; FUNGAL PERITONITIS; NYSTATIN PROPHYLAXIS; MUPIROCIN RESISTANCE; SIMULTANEOUS REMOVAL; CATHETER INFECTIONS; TRANSPORT KINETICS; CAPD PERITONITIS;
D O I
10.1007/s00467-008-1113-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Peritonitis remains a frequent complication of peritoneal dialysis in children and is the most common reason for technique failure. The microbiology is characterized by a predominance of Gram-positive organisms, with fungi responsible for less than 5% of episodes. Data collected by the International Pediatric Peritonitis Registry have revealed a worldwide variation in the bacterial etiology of peritonitis, as well as in the rate of culture-negative peritonitis. Risk factors for infection include young age, the absence of prophylactic antibiotics at catheter placement, spiking of dialysis bags, and the presence of a catheter exit-site or tunnel infection. Clinical symptoms at presentation are somewhat organism specific and can be objectively assessed with a Disease Severity Score. Whereas recommendations for empiric antibiotic therapy in children have been published by the International Society of Peritoneal Dialysis, epidemiologic data and antibiotic susceptibility data suggest that it may be desirable to take the patient- and center-specific history of microorganisms and their sensitivity patterns into account when prescribing initial therapy. The vast majority of patients are treated successfully and continue peritoneal dialysis, with the poorest outcome noted in patients with peritonitis secondary to Gram-negative organisms or fungi and in those with a relapsing infection.
引用
收藏
页码:425 / 440
页数:16
相关论文
共 127 条
[11]   A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin [J].
Bernardini, J ;
Piraino, B ;
Holley, J ;
Johnston, JR ;
Lutes, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (05) :695-700
[12]   Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients [J].
Bernardini, J ;
Bender, F ;
Florio, T ;
Sloand, J ;
PalmMontalbano, L ;
Fried, L ;
Piraino, B .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02) :539-545
[13]  
Blowey D L, 1994, Adv Perit Dial, V10, P297
[14]  
Blowey DL, 1998, ADV PERIT D, V14, P247
[15]  
Blowey DL, 2007, PERITON DIALYSIS INT, V27, P79
[16]  
Boer WH, 2003, PERITON DIALYSIS INT, V23, P33
[17]  
Boeschoten E. W., 2006, NEPHROLOGY DIALYSIS, V21, P31
[18]   Antimicrobial agents and catheter-related interventions to prevent peritonitis in peritoneal dialysis: Using evidence in the context of clinical practice [J].
Bonifati, C ;
Pansini, F ;
Torres, DD ;
Navaneethan, SD ;
Vaneethan, SD ;
Craig, JC ;
Strippoli, GFM .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2006, 29 (01) :41-49
[19]   Immunoglobulins in chronic renal failure of childhood:: Effects of dialysis modalities [J].
Bouts, AHM ;
Davin, JC ;
Krediet, RT ;
van der Weel, MB ;
Schröder, CH ;
Monnens, L ;
Nauta, J ;
Out, TA .
KIDNEY INTERNATIONAL, 2000, 58 (02) :629-637
[20]   INTRAPERITONEAL (IP) VANCOMYCIN THERAPY FOR CAPD PERITONITIS - A PROSPECTIVE, RANDOMIZED COMPARISON OF INTERMITTENT NU CONTINUOUS THERAPY [J].
BOYCE, NW ;
WOOD, C ;
THOMSON, NM ;
KERR, P ;
ATKINS, RC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 12 (04) :304-306